Warby Parker (WRBY) Competitors $16.90 +0.42 (+2.55%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$16.86 -0.04 (-0.27%) As of 05/2/2025 07:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock WRBY vs. GKOS, BLCO, INSP, NARI, SLNO, IRTC, TMDX, PRCT, NVST, and LMATShould you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include Glaukos (GKOS), Bausch + Lomb (BLCO), Inspire Medical Systems (INSP), Inari Medical (NARI), Soleno Therapeutics (SLNO), iRhythm Technologies (IRTC), TransMedics Group (TMDX), PROCEPT BioRobotics (PRCT), Envista (NVST), and LeMaitre Vascular (LMAT). These companies are all part of the "medical equipment" industry. Warby Parker vs. Glaukos Bausch + Lomb Inspire Medical Systems Inari Medical Soleno Therapeutics iRhythm Technologies TransMedics Group PROCEPT BioRobotics Envista LeMaitre Vascular Glaukos (NYSE:GKOS) and Warby Parker (NYSE:WRBY) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, valuation, dividends, profitability, risk, community ranking, analyst recommendations, institutional ownership and media sentiment. Is GKOS or WRBY more profitable? Warby Parker has a net margin of -4.39% compared to Glaukos' net margin of -39.04%. Warby Parker's return on equity of -8.26% beat Glaukos' return on equity.Company Net Margins Return on Equity Return on Assets Glaukos-39.04% -16.53% -10.61% Warby Parker -4.39%-8.26%-4.37% Does the MarketBeat Community prefer GKOS or WRBY? Glaukos received 408 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 65.29% of users gave Glaukos an outperform vote while only 45.37% of users gave Warby Parker an outperform vote. CompanyUnderperformOutperformGlaukosOutperform Votes45765.29% Underperform Votes24334.71% Warby ParkerOutperform Votes4945.37% Underperform Votes5954.63% Which has higher earnings and valuation, GKOS or WRBY? Warby Parker has higher revenue and earnings than Glaukos. Warby Parker is trading at a lower price-to-earnings ratio than Glaukos, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlaukos$383.48M13.04-$134.66M-$2.37-36.96Warby Parker$771.32M2.27-$63.20M-$0.17-99.41 Do analysts recommend GKOS or WRBY? Glaukos currently has a consensus price target of $137.62, suggesting a potential upside of 57.10%. Warby Parker has a consensus price target of $22.64, suggesting a potential upside of 33.98%. Given Glaukos' stronger consensus rating and higher possible upside, equities analysts plainly believe Glaukos is more favorable than Warby Parker.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Glaukos 1 Sell rating(s) 1 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.77Warby Parker 0 Sell rating(s) 6 Hold rating(s) 9 Buy rating(s) 1 Strong Buy rating(s) 2.69 Does the media prefer GKOS or WRBY? In the previous week, Glaukos had 13 more articles in the media than Warby Parker. MarketBeat recorded 28 mentions for Glaukos and 15 mentions for Warby Parker. Warby Parker's average media sentiment score of 1.07 beat Glaukos' score of 0.48 indicating that Warby Parker is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Glaukos 9 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral Warby Parker 8 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, GKOS or WRBY? Glaukos has a beta of 0.88, meaning that its stock price is 12% less volatile than the S&P 500. Comparatively, Warby Parker has a beta of 2, meaning that its stock price is 100% more volatile than the S&P 500. Do institutionals and insiders believe in GKOS or WRBY? 99.0% of Glaukos shares are held by institutional investors. Comparatively, 93.2% of Warby Parker shares are held by institutional investors. 6.4% of Glaukos shares are held by company insiders. Comparatively, 26.5% of Warby Parker shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryWarby Parker beats Glaukos on 10 of the 19 factors compared between the two stocks. Get Warby Parker News Delivered to You Automatically Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart WRBY vs. The Competition Export to ExcelMetricWarby ParkerOphthalmic goods IndustryStaples SectorNYSE ExchangeMarket Cap$1.75B$11.17B$17.40B$19.21BDividend YieldN/A0.96%2.93%4.01%P/E Ratio-62.5936.2115.7033.50Price / Sales2.272.874.1029.16Price / CashN/A14.5316.3917.52Price / Book5.492.446.294.55Net Income-$63.20M$224.27M$734.35M$1.02B7 Day Performance9.03%0.97%2.87%2.30%1 Month Performance7.01%6.89%5.30%8.54%1 Year Performance33.28%-20.56%-3.11%4.75% Warby Parker Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)WRBYWarby Parker3.8919 of 5 stars$16.90+2.5%$22.64+34.0%+33.3%$1.75B$771.32M-62.593,030Upcoming EarningsAnalyst UpgradeNews CoveragePositive NewsGKOSGlaukos4.7483 of 5 stars$93.68-3.1%$156.17+66.7%-17.8%$5.35B$383.48M-32.64780Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageBLCOBausch + Lomb3.8448 of 5 stars$13.65-0.6%$18.82+37.9%-15.7%$4.82B$4.79B-15.0012,500Earnings ReportAnalyst ForecastNews CoverageINSPInspire Medical Systems4.8626 of 5 stars$157.79-0.8%$218.90+38.7%-36.0%$4.70B$802.80M91.21760Upcoming EarningsNews CoverageNARIInari Medical0.7141 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800News CoveragePositive NewsSLNOSoleno Therapeutics4.6233 of 5 stars$73.64+0.5%$104.67+42.1%+66.7%$3.68BN/A-22.1830Upcoming EarningsNews CoveragePositive NewsIRTCiRhythm Technologies1.0293 of 5 stars$106.64+0.6%$119.73+12.3%+27.7%$3.40B$591.84M-29.301,790Earnings ReportAnalyst ForecastAnalyst RevisionNews CoverageGap UpTMDXTransMedics Group3.2571 of 5 stars$90.19-3.5%$122.70+36.0%-29.7%$3.05B$441.54M95.95210Upcoming EarningsAnalyst ForecastPositive NewsPRCTPROCEPT BioRobotics2.7686 of 5 stars$54.16+3.2%$90.00+66.2%-13.5%$2.97B$249.12M-27.77430Analyst RevisionNews CoverageGap UpNVSTEnvista3.9204 of 5 stars$15.97+0.2%$19.96+25.0%-10.7%$2.75B$2.51B-2.4612,700Earnings ReportAnalyst ForecastAnalyst RevisionNews CoveragePositive NewsLMATLeMaitre Vascular2.8258 of 5 stars$91.54-0.1%$98.14+7.2%+6.0%$2.07B$219.86M50.02490Earnings ReportDividend AnnouncementNews CoverageGap Down Related Companies and Tools Related Companies GKOS Competitors BLCO Competitors INSP Competitors NARI Competitors SLNO Competitors IRTC Competitors TMDX Competitors PRCT Competitors NVST Competitors LMAT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:WRBY) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredMost traders are panicking. We’re cashing inMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Warby Parker Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Warby Parker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy WRBY Stock Free WRBY Stock Alerts